A new batch of anti-cancer drugs and rare disease drugs will be reduced from this month

category:Internet
 A new batch of anti-cancer drugs and rare disease drugs will be reduced from this month


The above relevant policies are clear. Since March 1, 2019, general VAT taxpayers who produce, sell, wholesale and retail rare disease drugs can choose to pay VAT at a simple rate of 3%. The above taxpayers choose the simple method to calculate and pay VAT, which shall not be changed within 36 months. Starting from March 1, 2019, import value-added tax will be levied at a reduced rate of 3% on imported rare disease drugs.

Beijing Youth Daily reporter learned that the VAT reduction drugs include 45 kinds of anticancer drug preparations and raw materials, such as dacotinib tablets for non-small cell lung cancer, furquetinib capsules for metastatic colorectal cancer, and 14 rare disease drug preparations for multiple sclerosis, and nosinasheng sodium injection for spinal muscular atrophy u3002

Source: Zhang Zutao, editor in charge of Beijing Youth Daily_ NT5054